SARTORIUS STEDIM BIOTECH (DIM.PA) Fundamental Analysis & Valuation

EPA:DIM • FR0013154002

Current stock price

169.1 EUR
+1.4 (+0.83%)
Last:

This DIM.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

5

1. DIM.PA Profitability Analysis

1.1 Basic Checks

  • In the past year DIM was profitable.
  • DIM had a positive operating cash flow in the past year.
  • In the past 5 years DIM has always been profitable.
  • DIM had a positive operating cash flow in each of the past 5 years.
DIM.PA Yearly Net Income VS EBIT VS OCF VS FCFDIM.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

1.2 Ratios

  • DIM has a worse Return On Assets (3.33%) than 61.11% of its industry peers.
  • Looking at the Return On Equity, with a value of 6.50%, DIM is in line with its industry, outperforming 44.44% of the companies in the same industry.
  • DIM has a Return On Invested Capital of 6.11%. This is comparable to the rest of the industry: DIM outperforms 55.56% of its industry peers.
  • DIM had an Average Return On Invested Capital over the past 3 years of 5.23%. This is below the industry average of 9.09%.
  • The 3 year average ROIC (5.23%) for DIM is below the current ROIC(6.11%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 3.33%
ROE 6.5%
ROIC 6.11%
ROA(3y)3.15%
ROA(5y)7.45%
ROE(3y)7.54%
ROE(5y)16.68%
ROIC(3y)5.23%
ROIC(5y)11.87%
DIM.PA Yearly ROA, ROE, ROICDIM.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

1.3 Margins

  • Looking at the Profit Margin, with a value of 8.96%, DIM is in the better half of the industry, outperforming 61.11% of the companies in the same industry.
  • In the last couple of years the Profit Margin of DIM has declined.
  • DIM has a better Operating Margin (17.72%) than 66.67% of its industry peers.
  • In the last couple of years the Operating Margin of DIM has declined.
  • The Gross Margin of DIM (45.33%) is better than 61.11% of its industry peers.
  • In the last couple of years the Gross Margin of DIM has declined.
Industry RankSector Rank
OM 17.72%
PM (TTM) 8.96%
GM 45.33%
OM growth 3Y-16.3%
OM growth 5Y-7.16%
PM growth 3Y-29.07%
PM growth 5Y-12.64%
GM growth 3Y-4.79%
GM growth 5Y-2.9%
DIM.PA Yearly Profit, Operating, Gross MarginsDIM.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40 50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. DIM.PA Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so DIM is destroying value.
  • Compared to 1 year ago, DIM has about the same amount of shares outstanding.
  • The number of shares outstanding for DIM has been increased compared to 5 years ago.
  • The debt/assets ratio for DIM has been reduced compared to a year ago.
DIM.PA Yearly Shares OutstandingDIM.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M
DIM.PA Yearly Total Debt VS Total AssetsDIM.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

2.2 Solvency

  • DIM has an Altman-Z score of 3.85. This indicates that DIM is financially healthy and has little risk of bankruptcy at the moment.
  • DIM has a Altman-Z score of 3.85. This is in the better half of the industry: DIM outperforms 72.22% of its industry peers.
  • The Debt to FCF ratio of DIM is 8.69, which is on the high side as it means it would take DIM, 8.69 years of fcf income to pay off all of its debts.
  • The Debt to FCF ratio of DIM (8.69) is comparable to the rest of the industry.
  • A Debt/Equity ratio of 0.49 indicates that DIM is not too dependend on debt financing.
  • The Debt to Equity ratio of DIM (0.49) is better than 66.67% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.49
Debt/FCF 8.69
Altman-Z 3.85
ROIC/WACC0.7
WACC8.68%
DIM.PA Yearly LT Debt VS Equity VS FCFDIM.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

2.3 Liquidity

  • A Current Ratio of 1.02 indicates that DIM should not have too much problems paying its short term obligations.
  • The Current ratio of DIM (1.02) is worse than 61.11% of its industry peers.
  • A Quick Ratio of 0.53 indicates that DIM may have some problems paying its short term obligations.
  • DIM has a worse Quick ratio (0.53) than 66.67% of its industry peers.
Industry RankSector Rank
Current Ratio 1.02
Quick Ratio 0.53
DIM.PA Yearly Current Assets VS Current LiabilitesDIM.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. DIM.PA Growth Analysis

3.1 Past

  • DIM shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 25.71%, which is quite impressive.
  • DIM shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 1.13% yearly.
  • The Revenue has been growing slightly by 6.74% in the past year.
  • Measured over the past years, DIM shows a quite strong growth in Revenue. The Revenue has been growing by 9.21% on average per year.
EPS 1Y (TTM)25.71%
EPS 3Y-20.14%
EPS 5Y1.13%
EPS Q2Q%8.74%
Revenue 1Y (TTM)6.74%
Revenue growth 3Y-5.29%
Revenue growth 5Y9.21%
Sales Q2Q%2.78%

3.2 Future

  • Based on estimates for the next years, DIM will show a quite strong growth in Earnings Per Share. The EPS will grow by 19.04% on average per year.
  • The Revenue is expected to grow by 11.26% on average over the next years. This is quite good.
EPS Next Y19.6%
EPS Next 2Y19.98%
EPS Next 3Y19.05%
EPS Next 5Y19.04%
Revenue Next Year7.37%
Revenue Next 2Y8.99%
Revenue Next 3Y9.53%
Revenue Next 5Y11.26%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
DIM.PA Yearly Revenue VS EstimatesDIM.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2B 4B 6B
DIM.PA Yearly EPS VS EstimatesDIM.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5 10

More info and screens

Find the best growth stocksShow best growing peers

1

4. DIM.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 38.43, which means the current valuation is very expensive for DIM.
  • 72.22% of the companies in the same industry are cheaper than DIM, based on the Price/Earnings ratio.
  • The average S&P500 Price/Earnings ratio is at 25.60. DIM is valued rather expensively when compared to this.
  • DIM is valuated quite expensively with a Price/Forward Earnings ratio of 32.13.
  • Based on the Price/Forward Earnings ratio, DIM is valued a bit more expensive than 66.67% of the companies in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 22.84, DIM is valued a bit more expensive.
Industry RankSector Rank
PE 38.43
Fwd PE 32.13
DIM.PA Price Earnings VS Forward Price EarningsDIM.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • DIM's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. DIM is more expensive than 66.67% of the companies in the same industry.
  • DIM's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 55.05
EV/EBITDA 22.02
DIM.PA Per share dataDIM.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates DIM does not grow enough to justify the current Price/Earnings ratio.
  • A more expensive valuation may be justified as DIM's earnings are expected to grow with 19.05% in the coming years.
PEG (NY)1.96
PEG (5Y)34.07
EPS Next 2Y19.98%
EPS Next 3Y19.05%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

4

5. DIM.PA Dividend Analysis

5.1 Amount

  • DIM has a yearly dividend return of 0.42%, which is pretty low.
  • Compared to an average industry Dividend Yield of 0.52, DIM has a dividend in line with its industry peers.
  • Compared to an average S&P500 Dividend Yield of 1.90, DIM's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.42%

5.2 History

  • The dividend of DIM is nicely growing with an annual growth rate of 15.19%!
Dividend Growth(5Y)15.19%
Div Incr Years0
Div Non Decr Years2
DIM.PA Yearly Dividends per shareDIM.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1

5.3 Sustainability

  • DIM pays out 25.24% of its income as dividend. This is a sustainable payout ratio.
  • The dividend of DIM is growing, but earnings are growing more, so the dividend growth is sustainable.
DP25.24%
EPS Next 2Y19.98%
EPS Next 3Y19.05%
DIM.PA Yearly Income VS Free CF VS DividendDIM.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M
DIM.PA Dividend Payout.DIM.PA Dividend Payout, showing the Payout Ratio.DIM.PA Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

DIM.PA Fundamentals: All Metrics, Ratios and Statistics

SARTORIUS STEDIM BIOTECH

EPA:DIM (4/2/2026, 7:00:00 PM)

169.1

+1.4 (+0.83%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)02-03
Earnings (Next)04-23
Inst Owners11.98%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap16.46B
Revenue(TTM)2.97B
Net Income(TTM)265.80M
Analysts84.21
Price Target240.49 (42.22%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.42%
Yearly Dividend0.69
Dividend Growth(5Y)15.19%
DP25.24%
Div Incr Years0
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-7.48%
Min EPS beat(2)-12.72%
Max EPS beat(2)-2.24%
EPS beat(4)2
Avg EPS beat(4)4.36%
Min EPS beat(4)-12.72%
Max EPS beat(4)22.18%
EPS beat(8)3
Avg EPS beat(8)-1.28%
EPS beat(12)3
Avg EPS beat(12)-11.72%
EPS beat(16)3
Avg EPS beat(16)-14.26%
Revenue beat(2)0
Avg Revenue beat(2)-4.06%
Min Revenue beat(2)-4.17%
Max Revenue beat(2)-3.94%
Revenue beat(4)2
Avg Revenue beat(4)-1.07%
Min Revenue beat(4)-4.17%
Max Revenue beat(4)3.52%
Revenue beat(8)4
Avg Revenue beat(8)-1.65%
Revenue beat(12)5
Avg Revenue beat(12)-1.63%
Revenue beat(16)6
Avg Revenue beat(16)-1.17%
PT rev (1m)-0.45%
PT rev (3m)-1.92%
EPS NQ rev (1m)-2.22%
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-2%
Revenue NQ rev (1m)0.11%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.06%
Revenue NY rev (3m)-1.2%
Valuation
Industry RankSector Rank
PE 38.43
Fwd PE 32.13
P/S 5.55
P/FCF 55.05
P/OCF 23.78
P/B 4.02
P/tB N/A
EV/EBITDA 22.02
EPS(TTM)4.4
EY2.6%
EPS(NY)5.26
Fwd EY3.11%
FCF(TTM)3.07
FCFY1.82%
OCF(TTM)7.11
OCFY4.21%
SpS30.49
BVpS42.03
TBVpS-3.39
PEG (NY)1.96
PEG (5Y)34.07
Graham Number64.5
Profitability
Industry RankSector Rank
ROA 3.33%
ROE 6.5%
ROCE 8%
ROIC 6.11%
ROICexc 6.56%
ROICexgc 23.58%
OM 17.72%
PM (TTM) 8.96%
GM 45.33%
FCFM 10.08%
ROA(3y)3.15%
ROA(5y)7.45%
ROE(3y)7.54%
ROE(5y)16.68%
ROIC(3y)5.23%
ROIC(5y)11.87%
ROICexc(3y)5.56%
ROICexc(5y)12.62%
ROICexgc(3y)18.67%
ROICexgc(5y)31.48%
ROCE(3y)6.85%
ROCE(5y)15.55%
ROICexgc growth 3Y-18%
ROICexgc growth 5Y-10.32%
ROICexc growth 3Y-31.81%
ROICexc growth 5Y-17.24%
OM growth 3Y-16.3%
OM growth 5Y-7.16%
PM growth 3Y-29.07%
PM growth 5Y-12.64%
GM growth 3Y-4.79%
GM growth 5Y-2.9%
F-Score7
Asset Turnover0.37
Health
Industry RankSector Rank
Debt/Equity 0.49
Debt/FCF 8.69
Debt/EBITDA 2.39
Cap/Depr 123.61%
Cap/Sales 13.25%
Interest Coverage 3.42
Cash Conversion 82.03%
Profit Quality 112.49%
Current Ratio 1.02
Quick Ratio 0.53
Altman-Z 3.85
F-Score7
WACC8.68%
ROIC/WACC0.7
Cap/Depr(3y)145.19%
Cap/Depr(5y)180.27%
Cap/Sales(3y)14.18%
Cap/Sales(5y)13.22%
Profit Quality(3y)157.37%
Profit Quality(5y)116.81%
High Growth Momentum
Growth
EPS 1Y (TTM)25.71%
EPS 3Y-20.14%
EPS 5Y1.13%
EPS Q2Q%8.74%
EPS Next Y19.6%
EPS Next 2Y19.98%
EPS Next 3Y19.05%
EPS Next 5Y19.04%
Revenue 1Y (TTM)6.74%
Revenue growth 3Y-5.29%
Revenue growth 5Y9.21%
Sales Q2Q%2.78%
Revenue Next Year7.37%
Revenue Next 2Y8.99%
Revenue Next 3Y9.53%
Revenue Next 5Y11.26%
EBIT growth 1Y41.93%
EBIT growth 3Y-20.72%
EBIT growth 5Y1.39%
EBIT Next Year55.74%
EBIT Next 3Y26.51%
EBIT Next 5Y22.89%
FCF growth 1Y-37.09%
FCF growth 3Y18.06%
FCF growth 5Y3.02%
OCF growth 1Y-15.08%
OCF growth 3Y4.17%
OCF growth 5Y10.67%

SARTORIUS STEDIM BIOTECH / DIM.PA Fundamental Analysis FAQ

What is the fundamental rating for DIM stock?

ChartMill assigns a fundamental rating of 5 / 10 to DIM.PA.


What is the valuation status of SARTORIUS STEDIM BIOTECH (DIM.PA) stock?

ChartMill assigns a valuation rating of 1 / 10 to SARTORIUS STEDIM BIOTECH (DIM.PA). This can be considered as Overvalued.


How profitable is SARTORIUS STEDIM BIOTECH (DIM.PA) stock?

SARTORIUS STEDIM BIOTECH (DIM.PA) has a profitability rating of 5 / 10.


Can you provide the PE and PB ratios for DIM stock?

The Price/Earnings (PE) ratio for SARTORIUS STEDIM BIOTECH (DIM.PA) is 38.43 and the Price/Book (PB) ratio is 4.02.


Can you provide the dividend sustainability for DIM stock?

The dividend rating of SARTORIUS STEDIM BIOTECH (DIM.PA) is 4 / 10 and the dividend payout ratio is 25.24%.